Pharmacy delivery is the most-requested diversification segment among regional ride-hailing operators looking for recurring income beyond passenger trips. The surface logic is attractive: orders are compact, customers buy frequently, routes are short, and the willingness to pay for convenience is already established in users who order food or groceries on their phones. But medications are regulated products, and across most LATAM countries there is health legislation defining who may deliver certain types of medications, how that delivery must be documented, and what liability falls on the provider when something goes wrong. The operator who enters the segment without understanding those restrictions delivers pharmacy packages like any other package — and at some point that omission costs them the contract.
This article is for operators with an active operation evaluating pharmacy delivery as an additional revenue line, whether through a direct agreement with an independent pharmacy or a regional chain. The central argument is that operators who win and retain those contracts don't do so by being cheapest or fastest — they do so because they can document that their operation understands which types of medications they can handle responsibly, what record the pharmacy needs to meet its local health regulations, and what protocol the driver follows when one of the three exception scenarios every pharmacy has lived through occurs: the client isn't home, the medication requires recipient identity verification, or the order address doesn't match expectations. That specific operational knowledge is the real differentiator, not price.
The pharmacy with delivery demand and no formal logistics partner yet
In mid-size LATAM cities, the independent pharmacy processing 150 to 400 prescriptions daily already receives home delivery requests at a frequency its current structure can't consistently serve. The solution most have adopted is informal: the pharmacy's own driver, a staff member's relative, or the restaurant delivery person who takes secondary orders between shifts. That model generates documented problems — deliveries without formal records, medications arriving at the wrong address with no defined return process, drivers without training in regulated product handling — but it remains the norm because no delivery operator has presented an alternative the pharmacy can adopt without completely overhauling its internal process.
The opportunity for the regional ride-hailing operator is not to compete with large-scale delivery platforms, which in cities of 200,000 to 500,000 inhabitants frequently have inconsistent coverage or commission rates the independent pharmacy can't absorb. It's to position as a compliance-ready logistics partner, not as a marketplace taking 25 to 30 percent of order value. The model that works is the direct contract: the operator commits to a daily delivery count in a defined radius with a time SLA, the pharmacy pays a fixed rate per delivery, and each delivery record remains available when the pharmacy needs to respond to a complaint or audit. That model gives the pharmacy something no marketplace offers: process control and auditable documentation.
Which medications your operation can handle — and which it cannot
The first step before presenting any proposal to a pharmacy is understanding medication classification in terms of delivery restrictions. Not all medications carry the same requirements, and assuming they do is the most common error operators make when entering the segment unprepared. The most operationally relevant classification has five levels the driver and operator must know before the first order:
- OTC (over-the-counter): no recipient restrictions, no identity verification required, standard delivery with timestamp and a photo of the package at the door
- Non-controlled prescription: verify the recipient is an adult matching the order name — never deliver to a minor without a responsible adult present
- Controlled medications (psychotropics, opioids): in most LATAM countries regulations prohibit subcontracting these to third parties — this tier is not available to external operators and pharmacies already know it
- Active cold chain (2–8°C): insulins, injectable biologics, and GLP-1 analogs require a certified medical transport box and a recorded initial and final temperature
- Temperature-sensitive ambient (15–25°C): some antibiotic and antiviral powders need ambient temperature protection and shade from direct sunlight, with no refrigerated box required
The operator who is transparent with the pharmacy about the controlled medication restriction builds more trust than one who promises to handle any product type without studying the regulations. Most independent pharmacies already know they can't subcontract controlled drug delivery — the operator who confirms that understanding in their proposal demonstrates they know the segment. The initial contract focus should be on OTC and non-controlled prescription medications, which represent 85 to 95 percent of a standard pharmacy's home delivery order volume and require no special equipment investment for most of the catalog.
The five delivery records the pharmacy must keep
Pharmacies in LATAM are subject to health regulations including sales and home delivery record requirements. The specifics vary by country — COFEPRIS in Mexico, INVIMA in Colombia, ANMAT in Argentina — but the principle is consistent: the pharmacy must demonstrate that the medication it dispensed reached the correct recipient, at the documented time, and in adequate condition. For the operator, that translates to five data points the driver must record at each delivery: exact delivery time, recipient name, confirmation that the recipient is the named person or an authorized adult family member, package condition at delivery, and proof of reception — a photo at the door or the recipient's digital signature. A five-field form in the driver's app is sufficient for 90 percent of private pharmacies in LATAM.
The operator who delivers those records in a retrievable format — exportable as PDF or CSV when the pharmacy requests it — has a direct advantage over the informal courier delivering without an auditable record. That documentation is not just added value: in cities where health authorities have begun including third-party delivery within the scope of their pharmacy good practices inspections — a growing trend in Mexico and Colombia since 2024 — it is the difference between a pharmacy that passes a review and one that faces a fine for failing to demonstrate its delivery process meets its health registration standards. The operator who understands that regulatory pressure before the pharmacy explicitly articulates it becomes a partner, not just a vendor.
Cold chain in pharmacy delivery: different from hospital logistics
The operator with hospital logistics experience knows cold chain principles, but pharmacy delivery has an important context difference: in hospital logistics, the cold chain ends at a controlled facility — from one lab or clinic to another. In pharmacy delivery, it ends at the patient's home, which might be on a fourth floor with no elevator, in a high-sun-exposure area in midsummer, or received by someone on a work call with no time to refrigerate immediately. That difference changes container requirements and the driver's protocol. For insulins, injectable biologics, and GLP-1 analogs — the highest-ticket and most frequent cold-chain products in a typical pharmacy — the standard is maintaining 2 to 8°C from when they leave the pharmacy's refrigerator until the patient places them in their own fridge.
Cold-chain medications represent 8 to 15 percent of a standard pharmacy's home delivery order volume, but they carry the highest average ticket and the most serious consequences if delivered out of temperature. The equipment the driver needs for this segment is a medical transport box with certified gel cold packs — not frozen water, which generates condensation that can damage packaging — and a digital temperature logger with an initial and final reading. The investment runs $2,500 to $5,000 pesos per driver and is justified with 12 to 15 monthly cold-chain deliveries at market rate, which ranges from $150 to $300 pesos per delivery. The operator who equips three or four drivers with that gear can offer the pharmacy cold-chain coverage across any time window without compromising availability for standard orders.
How to structure the contract: minimum volume, zones, and the protocol when the client isn't home
The most common error in the first pharmacy delivery contract is accepting an on-demand structure: the pharmacy requests a delivery when it needs one, the operator assigns at a variable rate, and there's no volume or availability commitment from either party. That model may generate sporadic income but doesn't produce the stability the operator needs or the guaranteed availability the pharmacy needs. The structure that works is the monthly zone-and-schedule contract: the operator guarantees drivers available in the pharmacy's coverage radius during operating hours, the pharmacy commits to a monthly minimum volume — for example, 80 OTC and standard prescription deliveries plus 10 cold-chain — and both parties have a fixed price per category with a documented surcharge for out-of-zone or after-hours deliveries.
The contract element most often left undefined and the one generating the most conflicts in actual operation is the procedure when the client isn't home. The driver who arrives at the address and finds no recipient has three options — wait, leave the package, or return — and each has different consequences for the medication, the client, and the driver's income. The standard most pharmacies with established delivery have adopted is: the driver waits five minutes, attempts contact at the order's phone number, and if there's no response, returns the package to the pharmacy with a timestamp and failed-attempt reason on record. The pharmacy logs the attempt and the operator bills the service without discount, since the driver completed the trip. That procedure must be written into the contract — not assumed — because it is the most frequent tension point and the one that breaks the relationship fastest when left undefined.
The four errors that end a pharmacy delivery contract
There are four situations that, without documented protocol, end pharmacy delivery contracts or prevent them from starting. The first is delivering a prescription medication to a minor without a responsible adult present — regulatorily prohibited in most LATAM countries and liability the pharmacy bears before its health authority. A single incident of this type, without documented driver training, is enough for the pharmacy to cancel the contract regardless of the volume the operator is generating. The second is a cold-chain medication arriving out of temperature — the driver arrived without the correct box or the box didn't maintain temperature on an extremely hot day. In that case, the medication must return to the pharmacy, not be delivered; the driver who delivers it anyway to avoid the return trip creates a health liability the operator cannot cover after the fact.
The third is delivery to an incorrect address due to a typing error or ambiguous address, resulting in medication in the hands of someone not corresponding to the order. The correct protocol is to attempt to recover the package and report the error with a timestamp and the actual delivery address on record. The fourth is lost documentation when the pharmacy faces an audit: if the operator doesn't store delivery records for at least six months, the pharmacy receiving a health inspection will have a documentation gap the operator created. A single failure of this type is enough for the pharmacy to withhold a positive reference and block the operator from the conversation with the segment's next clients. None of these four errors require complex technology to prevent — they require written protocol and documented training the operator can show the pharmacy director before signing.
What convinced me to switch to the current operator was that he sent me in writing how he handles the case where the client isn't home and the case of delivery to a minor. COFEPRIS had asked me about exactly that in my last registration renewal. My previous courier never understood what I was talking about when I explained the issue. With this operator the conversation was reversed: he told me what I would need before I asked for it. That's someone who can be a partner, not just a delivery person.
Pharmacy delivery is not a segment where the operator wins by being fastest or cheapest. It is one where the operator wins who can demonstrate, before the pharmacy has a problem, that their operation understands the restrictions of the product they handle. That demonstration requires no costly certifications — it requires the operator to have thought through the four exception scenarios in advance and to have a written response for each. The operator who arrives at the first meeting with a two-page document describing their medication delivery protocol — product classification, delivery restrictions, documentation records, and procedure when the client is absent — has already won half the conversation before price is mentioned.
The moment to enter this segment in mid-size LATAM cities is 2026, not 2028. Independent pharmacies currently operating with informal couriers are already receiving more requests than they can handle, and health authorities in Mexico, Colombia, and Peru have begun including third-party delivery within the scope of their pharmacy good practices inspections. The pharmacy operating with an informal courier today will need a documented partner within the next 18 to 24 months — not by preference but by regulatory requirement. The operator who arrives with protocol before that requirement lands signs with the pharmacy that already knows them and trusts them, before regulation forces the pharmacy to look, not after.
